1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone
C24H18N6OS — CID 137115150
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone
1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone (PubChem CID 137115150) has the molecular formula C24H18N6OS and a molecular weight of 438.52 g/mol. Its IUPAC name is 1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone.
Molecular Properties
| Compound Name | 1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone |
|---|---|
| PubChem CID | 137115150 |
| Molecular Formula | C24H18N6OS |
| Molecular Weight | 438.52 g/mol |
| Exact Mass | 438.13 |
| IUPAC Name | 1-[5-[2-[5-(1-methylpyrazol-4-yl)-1H-pyrazolo[4,3-b]pyridin-3-yl]-1H-indol-4-yl]thiophen-2-yl]ethanone |
| SMILES | CC(=O)c1ccc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cnn(C)c6)nc45)cc23)s1 |
| InChI | InChI=1S/C24H18N6OS/c1-13(31)21-8-9-22(32-21)15-4-3-5-18-16(15)10-20(26-18)24-23-19(28-29-24)7-6-17(27-23)14-11-25-30(2)12-14/h3-12,26H,1-2H3,(H,28,29) |
| InChIKey | XDYHMZRUSULDPM-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 92.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.52 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137115150 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.